Diffusion-weighted magnetic resonance spectroscopy benefits from the use of ultra-strong gradients. Slow diffusing metabolites necessitate a large range of b-values to accurately model the diffusion properties. Ultra-strong gradients open the possibility of higher b-values and reduced diffusion times, alleviating some of these constraints. We present initial data acquired with DW-PRESS on a 300mT/m gradient Connectom scanner, and introduce the practical considerations associated with ultra-strong gradients.
We are grateful to Fabrizio Fasano from Siemens Healthcare GmbH for his support.
CMWT is supported by a Rubicon grant (680-50-1527) from the Netherlands Organisation for Scientific Research (NWO) and a Sir Henry Wellcome Fellowship (215944/Z/19/Z).
CJ, LM, and DKJ are supported by a Wellcome Trust Strategic Award (104943/Z/14/Z), and DKJ by a Wellcome Trust Investigator Award (096646/Z/11/Z).
[1] Choi, J. K., Dedeoglu, A., & Jenkins, B. G. (2007). Application of MRS to mouse models of neurodegenerative illness. NMR in Biomedicine: An International Journal Devoted to the Development and Application of Magnetic Resonance In vivo, 20(3), 216-237.
[2] Ellegood, J., Hanstock, C. C., & Beaulieu, C. (2011). Considerations for measuring the fractional anisotropy of metabolites with diffusion tensor spectroscopy. NMR in Biomedicine, 24(3), 270-280.
[3] Jones, D. K., Alexander, D. C., Bowtell, R., Cercignani, M., Dell'Acqua, F., McHugh, D. J., ... & Tax, C. M. (2018). Microstructural imaging of the human brain with a ‘super-scanner’: 10 key advantages of ultra-strong gradients for diffusion MRI. NeuroImage, 182, 8-38.
[4] Setsompop, K., Kimmlingen, R., Eberlein, E., Witzel, T., Cohen-Adad, J., McNab, J. A., ... & Cauley, S. F. (2013). Pushing the limits of in vivo diffusion MRI for the Human Connectome Project. Neuroimage, 80, 220-233.
[5]Bammer, R., Markl, M., Barnett, A., Acar, B., Alley, M. T., Pelc, N. J., ... & Moseley, M. E. (2003). Analysis and generalized correction of the effect of spatial gradient field distortions in diffusion‐weighted imaging. Magnetic Resonance in Medicine: An Official Journal of the International Society for Magnetic Resonance in Medicine, 50(3), 560-569.
[6] Hall, E. L., Stephenson, M. C., Price, D., & Morris, P. G. (2014). Methodology for improved detection of low concentration metabolites in MRS: optimised combination of signals from multi-element coil arrays. Neuroimage, 86, 35-42.
[7] Near, J., Edden, R., Evans, C. J., Paquin, R., Harris, A., & Jezzard, P. (2015). Frequency and phase drift correction of magnetic resonance spectroscopy data by spectral registration in the time domain. Magnetic Resonance in Medicine, 73(1), 44-50.
[8] Vanhamme, L., Fierro, R. D., Van Huffel, S., & de Beer, R. (1998). Fast removal of residual water in proton spectra. Journal of Magnetic Resonance, 132(2), 197-203.
[9] Wilson, M., Reynolds, G., Kauppinen, R. A., Arvanitis, T. N., & Peet, A. C. (2011). A constrained least‐squares approach to the automated quantitation of in vivo 1H magnetic resonance spectroscopy data. Magnetic resonance in medicine, 65(1), 1-12.
[10] Ronen, I., Budde, M., Ercan, E., Annese, J., Techawiboonwong, A., & Webb, A. (2014). Microstructural organization of axons in the human corpus callosum quantified by diffusion-weighted magnetic resonance spectroscopy of N-acetylaspartate and post-mortem histology. Brain Structure and Function, 219(5), 1773-1785.
[11] Kan, H. E., Techawiboonwong, A., Van Osch, M. J., Versluis, M. J., Deelchand, D. K., Henry, P. G., ... & Ronen, I. (2012). Differences in apparent diffusion coefficients of brain metabolites between grey and white matter in the human brain measured at 7 T. Magnetic resonance in medicine, 67(5), 1203-1209.
[12] Najac, C., Branzoli, F., Ronen, I., & Valette, J. (2016). Brain intracellular metabolites are freely diffusing along cell fibers in grey and white matter, as measured by diffusion-weighted MR spectroscopy in the human brain at 7 T. Brain Structure and Function, 221(3), 1245-1254.
[13] Cao, P., & Wu, E. X. (2017). In vivo diffusion MRS investigation of non‐water molecules in biological tissues. NMR in Biomedicine, 30(3), e3481.
[14] Ronen, I., Ercan, E., & Webb, A. (2013). Axonal and glial microstructural information obtained with diffusion-weighted magnetic resonance spectroscopy at 7T. Frontiers in integrative neuroscience, 7, 13.
[15] Ganji, S. K., Banerjee, A., Patel, A. M., Zhao, Y. D., Dimitrov, I. E., Browning, J. D., ... & Choi, C. (2012). T2 measurement of J‐coupled metabolites in the human brain at 3T. NMR in biomedicine, 25(4), 523-529.
[16] Ke, Y., Cohen, B. M., Lowen, S., Hirashima, F., Nassar, L., & Renshaw, P. F. (2002). Biexponential transverse relaxation (T2) of the proton MRS creatine resonance in human brain. Magnetic Resonance in Medicine: An Official Journal of the International Society for Magnetic Resonance in Medicine, 47(2), 232-238.
Fig.1. This figure highlights the potential of ultra-strong gradients for DW-MRS. The left panel shows the maximum achievable b-value for DW-PRESS as a function of the echo time for three gradient strengths; 40, 80, and 300 mT/m. The right panel shows the SNR gains resulting from reduced echo time, as a function of b-value. SNR gains calculated using estimates for metabolite T2 [15, 16].